Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.

Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.

Item
http://www.wikidata.org/entity/Q36235936
Systemic therapy in bladder cancerHer2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.Emerging drugs for urothelial (bladder) cancer.Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer.Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.Different stages in drug development for muscle-invasive bladder cancer.Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer.Activating HER2 mutations as emerging targets in multiple solid cancers.Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer.
P2860

Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.

Item
http://www.wikidata.org/entity/Q36235936
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Phase III, Double-Blind, Rando ...... ive Metastatic Bladder Cancer.
@ast
Phase III, Double-Blind, Rando ...... ive Metastatic Bladder Cancer.
@en
type
label
Phase III, Double-Blind, Rando ...... ive Metastatic Bladder Cancer.
@ast
Phase III, Double-Blind, Rando ...... ive Metastatic Bladder Cancer.
@en
prefLabel
Phase III, Double-Blind, Rando ...... ive Metastatic Bladder Cancer.
@ast
Phase III, Double-Blind, Rando ...... ive Metastatic Bladder Cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Phase III, Double-Blind, Rando ...... tive Metastatic Bladder Cancer
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921